COCH — Envoy Medical Balance Sheet
0.000.00%
- $28.79m
- $42.02m
- $0.23m
Annual balance sheet for Envoy Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Cash and Short Term Investments | 1.12 | 0.183 | 4.22 | 5.48 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.088 | 0.041 | 0.246 | 0.818 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Current Assets | 2.44 | 1.65 | 7.46 | 9.38 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.188 | 0.908 | 0.815 | 2.15 |
Total Assets | 2.62 | 2.56 | 8.27 | 11.5 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 1.38 | 2.52 | 7.29 | 7.54 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 27.6 | 38.8 | 10 | 30.4 |
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -25 | -36.2 | -1.78 | -18.8 |
Total Liabilities & Shareholders' Equity | 2.62 | 2.56 | 8.27 | 11.5 |
Total Common Shares Outstanding |